A new publication in Nature Communications can revolutionize the treatment of Parkinson's patients
The results are just published in Nature Communications under the title "Enhanced production of mesencephalic dopaminergic neurons from lineage-restricted human undifferentiated stem cells."
In the new research findings, DANDRITE group leader and Associate Professor Mark Denham has developed a method that ensures much higher purity of the so-called dopamine cells, which are crucial in connection with Parkinson's disease.
"Stem cells offer promising potential for treating Parkinson's disease by transforming into specific nerve cells. However, the precision of this transformation poses a significant challenge with current methods, resulting in low purity," ...













